FBIO

Fortress Biotech, Inc. - Common Stock (FBIO)

About Fortress Biotech, Inc. - Common Stock (FBIO)

Fortress Biotech, Inc. engages in the manufacture and commercialization of novel pharmaceutical products and product candidates. It operates through the Dermatology Product Sales and Pharmaceutical and Biotechnology Product Development segments. Its products include Ximino, Targadox, Exelderm, Ceracade, and Luxamend. The company was founded in 2006 and is headquartered in Bay Harbor Islands, FL.

Details

Daily high

$2.62

Daily low

$2.56

Price at open

$2.59

52 Week High

$4.53

52 Week Low

$2.18

Market cap

85.7M

Dividend yield

Volume

120,073

Avg. volume

428,310

P/E ratio

.97

Fortress Biotech, Inc. - Common Stock News